US sues Re­gen­eron over ‘hun­dreds of mil­lions’ in al­leged­ly in­flat­ed Medicare re­im­burse­ments for Eylea

Re­gen­eron Phar­ma­ceu­ti­cals has been ac­cused of ma­nip­u­lat­ing Medicare re­im­burse­ment for its eye drug Eylea. If found li­able, the com­pa­ny could end up pay­ing three times …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER